13 min listen
COVID-19 therapies update: There are three potential pathways forming a bridge to a vaccine
COVID-19 therapies update: There are three potential pathways forming a bridge to a vaccine
ratings:
Length:
18 minutes
Released:
Apr 13, 2020
Format:
Podcast episode
Description
You’ve probably heard the anti-malarial drug hydroxychloroqine is getting a hard look as a potential therapeutic agent in the fight against COVID-19. However, as Harvard Health Publishing senior faculty editor Dr. Rob Shmerling points out, evidence remains weak. On the brighter side, he points to three potential avenues in COVID-19 research where therapies may be put to use while a vaccine remains in development.
Released:
Apr 13, 2020
Format:
Podcast episode
Titles in the series (53)
Special Edition: Health in the news. Red meat less risky? And Zantac recall: We've been told for years it's wise to dial back on the consumption of red meat, especially processed red meat. But a study in the Annals of Internal Medicine suggested red meat can now be considered less of a risk. And heart burn sufferers were... by Living Better, Living Longer